期刊文献+

糖尿病肾病与肾素-血管紧张素-醛固酮系统的关系 被引量:9

Correlation between Diabetic Nephropathy and Renin-angiotensin-aldosterone System
暂未订购
导出
摘要 糖尿病肾病是一种尿蛋白排泄率增加,通常伴有血压升高和典型的视网膜病变的疾病。这种疾病的特点首先是出现蛋白尿,继而肾小球滤过率进行性下降,最终导致终末期肾脏病。糖尿病环境对糖尿病患者肾小球的损伤甚至加重是必要的,肾素-血管紧张素-醛固酮系统是生理功能颇为复杂的内分泌系统,对糖尿病肾病的预防、发生、发展有重要作用。肾素-血管紧张素-醛固酮系统阻断剂药物的应用在阻止糖尿病肾病的进展以及延缓发展到晚期肾脏病阶段是有效的方法。 Diabetic nephropathy(diabetic kidney disease)is defined as a rise in urinary albumin excretion rate,often associated with an increase in blood pressure,and typically with concomitant retinopathy.It is characterized firstly by albuminuria and then by a progressive decline in glomerular filtration rate,eventually resulting in end-stage renal disease(ESRD).A diabetic milieu is required for the diabetic glomerular lesion to develop,and renin-angiotensin-aldosterone system is an endocrine system with complex physiological functions,playing an important role in prevention,development and progression of diabetic nephropathy.Using drugs that block the renin-angiotensin-aldosterone system are effective strategies for preventing the development of diabetic nephropathy delaying the progression to more advanced stages of nephropathy.
作者 曹丹 郝丽荣
出处 《医学综述》 2012年第9期1386-1388,共3页 Medical Recapitulate
关键词 糖尿病肾病 肾素血管紧张素醛固酮系统 血管紧张素转化酶抑制剂 血管紧张素受体拮抗剂 醛固酮拮抗剂 Diabetic nephropathy Rennin-angiotensin-aldosterone system Angiotersin-converting-enzyme inhibitor Angiotensin receptor antagonist Aldosterone antagonist
  • 相关文献

参考文献17

  • 1刘红,杨卉.肾素血管紧张素系统与糖尿病肾病[J].安徽医药,2003,7(2):84-86. 被引量:6
  • 2Struthers AD, MacDonald TM. Review of aldosterone-and angiote- nin Ⅱ-induced target organ damage and prevention[ J]. Cardiovasc Res ,2004,61 (4) :663-670.
  • 3Arima S, Kohagura K, Xu HL, et al. Endothelium-derived nitric ox- ide modulates vascular action of aldasterone in renal arteriole [ J ]. Hypertension, 2004,43 ( 2 ) : 352 -357.
  • 4Cha DR,Kang YS,Han SY,et al. Role of aldosterone in diabetic ne- phropathy [ J ]. Nephrology ( Carlton ) ,2005,10 (Suppl) : $37 -39.
  • 5Siragy HM,Xue C. Local renal aldosterone production induces in- flammation and matrix formation in kidneys of diabetic rats [ J J. Exp Physio1,2008,93 ( 7 ) : 817 -824.
  • 6Lee SH, Yoo TH, Nam BY, et al. Activation of local aldosterone system within podocytes is involved in apoptosis under diabetic conditions [ J ]. Am J Physiol Renal Physio1,2009,297 ( 5 ) : F1381- F1390.
  • 7Mauer M, Zinman B, Gardiner R,et al. Renal and retinal effects of enalapril and losartan in type I diabetes[J]. N Engl J Med,2009, 361 ( 1 ) :40-51.
  • 8Makino H, Haneda M, Babazono T, et al. Prevention of transition from incipient to overt nephropathy with telmisartan in patients with type 2 diabetes[ Jl. Diabetes Care,2007,30(6) :1577-1578.
  • 9de Zeeuw D, Remuzzi G, Parring HH, et al. Proteinuria, a target for renoproteetion in patients with type 2 diabetic nephropathy:lessons from RENAAL[ J ]. Kidney Int,2004,65 (6) :2309-2320.
  • 10Ruggenenti P, Fassi A, Ilieva AP, et al. Bergamo nephrologic diabe- tes complications trial (BENEDICT) investigators preventing mi- croalbuminuria in type 2 diabetes [ J ]. N Engl J Med, 2004,351 (19) :1941-1951.

二级参考文献19

  • 1Unger T.The angiotensin type 2 receptor:Variations on an enigmatic theme[J],1999(17).
  • 2Marre M;Jeunemaitre X;Gallois.Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes:Genetic de la.Nephropathic Diabetic (GENDIAB) study group[J],1997.
  • 3EURODIAB controlled trial of lisinopril in IDDM.Effect of angiotensin converting enzyme (AEC) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients:,1998.
  • 4Doria A.Synthetic effect of angiotensin 2 type 1 receptor geno type and poor glycemic on risk of nephropathy in IDDM[J],1997.
  • 5Impeatatore G.Sib-pair linkage analysis for susceptibility gene for microvascular complications among pima indians with type 2 diabetes[J],1998(5).
  • 6Moczulski DK.Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3 q[J],1998(7).
  • 7Suzuki K;Souda S;Ikarashi T.Renoprotective effects of low-dose valsartan in type 2 diabetic patients with diabetic nephropathy[J],2002(03).
  • 8Houlihan CA;Akdeniz A;Tsalamandris C.Urinary transforming growth factor-beta excretion in patients with hypertension,type2 diabetes,and elevated albumin excretion rate:effects of angiotensin receptor blockade and sodium restriction[J],2002(06).
  • 9Agarwal R;Siva S;Dunn SR.Add-on angiotensin Ⅱ recepter blocked lowers urinary transforming growth factor-beta levels[J],2002(03).
  • 10Rossing K;Christensen PK;Jensen BR.Dual blockade of the renin-angiotensin system in diabetic nephropathy:A randomized double-blind crossover study[J],2002.

共引文献5

同被引文献86

引证文献9

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部